Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by garred1961on Jan 12, 2010 5:53pm

347 Views

Post# 16670674

RE: Any thoughts on this news

These were positive developments the last few days for sure. Bargaining chips with possible partners but not a home run. We can not increase our burn rate at this share price without someone with much deeper pockets. Hopefully these PR's will put a solid floor on the price and maybe help us move up. Management has been smart up to this point. Hopefully they will have a partership sooner rather then later.

garred

Bullboard Posts

Canopy Growth nears adjusted EBITDA profitability in Q2 2025